HCA Stock - HCA Healthcare, Inc.
Unlock GoAI Insights for HCA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B |
| Gross Profit | $10.55B | $9.63B | $9.05B | $9.68B | $7.26B |
| Gross Margin | 14.9% | 14.8% | 15.0% | 16.5% | 14.1% |
| Operating Income | $10.55B | $9.63B | $9.05B | $9.68B | $7.26B |
| Net Income | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B |
| Net Margin | 8.2% | 8.1% | 9.4% | 11.8% | 7.3% |
| EPS | $22.27 | $19.24 | $19.44 | $21.51 | $11.10 |
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 15th 2025 | Morgan Stanley | Downgrade | Underweight | $425 |
| October 14th 2025 | Goldman | Resumed | Buy | $470 |
| July 28th 2025 | Wolfe Research | Downgrade | Peer Perform | - |
| July 16th 2025 | BofA Securities | Downgrade | Neutral | $394 |
| May 29th 2025 | Wells Fargo | Upgrade | Equal Weight | $385 |
| April 15th 2025 | Robert W. Baird | Downgrade | Neutral | $336 |
| December 17th 2024 | JP Morgan | Resumed | Neutral | $380 |
| November 25th 2024 | Wells Fargo | Downgrade | Underweight | $320← $400 |
| November 22nd 2024 | Raymond James | Downgrade | Market Perform | - |
| October 11th 2024 | KeyBanc Capital Markets | Initiation | Overweight | $475 |
| September 3rd 2024 | Morgan Stanley | Initiation | Equal Weight | $427 |
| May 30th 2024 | Robert W. Baird | Initiation | Outperform | $396 |
| March 6th 2024 | Barclays | Initiation | Overweight | $356 |
| January 4th 2024 | Bernstein | Downgrade | Market Perform | $301← $277 |
| December 11th 2023 | Goldman | Downgrade | Neutral | $271 |
Earnings History & Surprises
HCAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 23, 2026 | — | — | — | — |
Q1 2026 | Jan 23, 2026 | $7.37 | — | — | — |
Q4 2025 | Oct 24, 2025 | $5.79 | $6.96 | +20.2% | ✓ BEAT |
Q3 2025 | Jul 25, 2025 | $6.29 | $6.84 | +8.7% | ✓ BEAT |
Q2 2025 | Apr 25, 2025 | $5.75 | $6.45 | +12.2% | ✓ BEAT |
Q1 2025 | Jan 24, 2025 | $6.13 | $6.22 | +1.5% | ✓ BEAT |
Q4 2024 | Oct 25, 2024 | $4.99 | $5.03 | +0.8% | ✓ BEAT |
Q3 2024 | Jul 23, 2024 | $4.85 | $5.53 | +14.0% | ✓ BEAT |
Q2 2024 | Apr 26, 2024 | $5.01 | $5.93 | +18.4% | ✓ BEAT |
Q1 2024 | Jan 30, 2024 | $5.06 | $5.93 | +17.2% | ✓ BEAT |
Q4 2023 | Oct 24, 2023 | $3.98 | $3.91 | -1.8% | ✗ MISS |
Q3 2023 | Jul 27, 2023 | $4.22 | $4.29 | +1.7% | ✓ BEAT |
Q2 2023 | Apr 21, 2023 | $3.93 | $4.93 | +25.4% | ✓ BEAT |
Q1 2023 | Jan 27, 2023 | $4.79 | $4.64 | -3.1% | ✗ MISS |
Q4 2022 | Oct 21, 2022 | $3.88 | $3.93 | +1.3% | ✓ BEAT |
Q3 2022 | Jul 22, 2022 | $3.70 | $4.21 | +13.8% | ✓ BEAT |
Q2 2022 | Apr 22, 2022 | $4.25 | $4.12 | -3.1% | ✗ MISS |
Q1 2022 | Jan 27, 2022 | $4.53 | $4.42 | -2.4% | ✗ MISS |
Q4 2021 | Oct 22, 2021 | $4.10 | $4.57 | +11.5% | ✓ BEAT |
Q3 2021 | Jul 20, 2021 | $3.16 | $4.37 | +38.3% | ✓ BEAT |
Latest News
Mizuho Maintains Outperform on HCA Healthcare, Raises Price Target to $520
📈 PositiveMorgan Stanley Downgrades HCA Healthcare to Underweight, Maintains Price Target to $425
📉 NegativeWells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $431
➖ NeutralShares of healthcare stocks are trading lower after the US Senate approved a deal clearing the path to ending the government shutdown. The deal does not include an extension of expiring Affordable Care Act subsidies
📉 NegativeJefferies Maintains Buy on HCA Healthcare, Raises Price Target to $525
📈 PositiveUBS Maintains Buy on HCA Healthcare, Raises Price Target to $525
📈 PositiveB of A Securities Maintains Neutral on HCA Healthcare, Raises Price Target to $470
📈 PositiveGoldman Sachs Maintains Buy on HCA Healthcare, Raises Price Target to $520
📈 PositiveHCA Healthcare shares are trading higher after multiple firms raised their price targets on the stock.
📈 PositiveTD Cowen Maintains Buy on HCA Healthcare, Raises Price Target to $490
📈 PositiveRBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $482
📈 PositiveBarclays Maintains Overweight on HCA Healthcare, Raises Price Target to $494
📈 PositiveStephens & Co. Maintains Overweight on HCA Healthcare, Raises Price Target to $500
📈 PositiveTruist Securities Maintains Buy on HCA Healthcare, Raises Price Target to $495
📈 PositiveOppenheimer Maintains Outperform on HCA Healthcare, Raises Price Target to $500
📈 PositiveMizuho Maintains Outperform on HCA Healthcare, Raises Price Target to $505
📈 PositiveKeybanc Maintains Overweight on HCA Healthcare, Raises Price Target to $475
📈 PositiveHCA Healthcare shares are trading higher after the company reported Q3 EPS and sales above expectations and raised its FY2025 EPS and sales guidance.
📈 PositiveHCA Healthcare Non-GAAP EPS of $6.96 beats by $1.23, revenue of $19.16B beats by $600M
📈 PositiveHCA Healthcare Raises FY2025 GAAP EPS Guidance from $25.50-$27.00 to $27.00-$28.00 vs $26.33 Est; Raises FY2025 Sales Guidance from $74.000B-$76.000B to $75.000B-$76.500B vs $75.020B Est
📈 PositiveFrequently Asked Questions about HCA
What is HCA's current stock price?
What is the analyst price target for HCA?
What sector is HCA Healthcare, Inc. in?
What is HCA's market cap?
Does HCA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to HCA for comparison